"Exciting" study explains why men are more vulnerable to

New Post Public Reply Private Reply Replies (0) Message Board
someconcerns
686
Quote:
"Exciting" study explains why men are more vulnerable to coronavirus

Men are more likely to die of Covid-19. The answer why could lie in the immune system
Emma Betuel
17 hours ago

Anyone can get Covid-19, but not everyone suffers the same consequences. For some, it's a disease with no symptoms; for others, it's deadly. Men are consistently more likely to die.

For instance, in Europe, the World Health Organization reports that men make up 58 percent of Covid-19 deaths. Higher rates of death for men have also been reported in China and in the US.

While scientists have known Covid-19 is killing more men than women, why that is hasn't been certain. Now, a new study is pointing scientists in a promising direction, suggesting that men's immune systems may handle the virus differently.

In a paper published Wednesday in Nature, scientists at Yale University led by Akiko Iwasaki report that men they studied with Covid-19 had a less robust T-cell response to the virus than women.

T-cells are specialized fighters within the immune system's arsenal. Some types of T-cells can destroy cells that have been infected with the virus, while other types help the body produce antibodies that can help stop the virus from infecting a cell.

That lower T-cell response seen in men was linked to future worsening of the disease, the scientists report.

This study is a deep dive into the immune system that illuminates a robust global trend: A July study on 10,962 Covid-19-related deaths helped solidify the idea that men have higher risks of death from Covid-19 compared to women of the same age.

Warner Greene, an immunologist and director of The Gladstone Center for HIV Cure Research, tells Inverse that this new paper is "provocative," "highly interesting," and done by a "super-talented group of investigators." It also hints at why men oftentimes are more at risk.
Mens' immune systems react differently to the coronavirus, a new study in Nature shows. PeopleImages/Getty Images

"I have the sense they are indeed getting at some of the fundamental gender differences that underlie the different responses of men and women to SARS-CoV-2 infection," he says.

Sabra Klein a professor of molecular microbiology and immunology at Johns Hopkins University agrees. She was also not involved with the research but tells Inverse that the research is “exciting” and provides "new clues" into why men's immune systems may lose the fight against Covid-19.

Men, women, and Covid-19– The study was conducted on a relatively small sample for the science world: 17 men and 22 women who were admitted to the hospital after testing positive for Covid-19.

In that cohort, people weren't in the ICU and weren't receiving any steroids to help boost immune response, so the scientists were able to see how their immune systems responded naturally to the virus. The team also included another group of 59 people, some of whom were admitted to the ICU with severe disease, and finally, a control group of non-infected healthcare workers.

Overall, the women with Covid-19 had elevated T-cell responses compared to men and healthy controls (the latter is expected).

Crucially, the study wasn't all good news for women: Some women also had higher levels of two types of cytokines. This is a group of signaling proteins that the immune system uses to communicate. Higher levels of these cytokines were linked to more severe disease progression, even though their T-cell responses weren't different from those with the lesser disease.

The encouraging takeaway — Greene says that this study suggests different men and women might benefit from different treatments.

In men, we may need to boost T-cell responses, perhaps through a vaccine, to prevent worsening disease.
In women, we may need to "blunt" certain cytokine responses early on during infection to prevent worsening disease.

Klein cautions that this study can't give us the whole story on sex and Covid-19. It does show that immune reactions may differ between sexes, but there are other biological differences like genetics or sex hormones (like estrogen or testosterone) that weren't measured here. These could also affect how the disease progresses in men and women.

"I think that this study provides exciting clues into the immune responses that differ between men and women who are infected with SARS-CoV-2, but does not tell us the mechanisms underlying why men are twice as likely to die from COVID-19," Klein says.

Because the average age of female study participants was about 60-years-old, the study authors suggest that sex hormones may not be as powerful a factor. This still leaves other avenues untapped.

"I anticipate this work will have high impact... "

For example, it's well-established that age increases risk for Covid-19. The paper suggests we might approach the age question, in relation to gender disparities and coronavirus, with a bit more nuance.

In men, the team found that the older the men got, the worse their T-cell response seemed to be. However, that wasn't the case for women. As Iwasaki told The New York Times, women as old as 90 "are still making pretty good, decent immune response."

The fact that women tend to have strong immune responses isn't exactly new. A 2018 PNAS paper found that female mice had stronger immune responses when given flu vaccines. Women's immune systems also tend to fare better against HIV once they're infected, a 2007 study on 2,620 patients found.

However, that strong response is not always a good thing: more women suffer from autoimmune diseases (where an overactive immune system attacks the body) than men do.

When it comes to Covid-19 the fact that women tend to carry on a robust T-cell response may prove to be helpful, especially if those cytokines that appear to make the disease worse can be managed. Those cell responses also offer a trail scientists could follow as they try to boost immunity in men. Klein says that this is a key finding:

"The more robust T cell responses in older women could be an important clue to protection and must be explored further," she says.

Greene's intuition says that this paper will spark many more like. Those may give us better answers.

"I anticipate this work will have high impact and will galvanize a large number of follow-up studies," he adds.

Abstract: A growing body of evidence indicates sex differences in the clinical outcomes of coronavirus disease 2019 (COVID-19)1–5. However, whether immune responses against SARS-CoV-2 differ between sexes, and whether such differences explain male susceptibility to COVID-19, is currently unknown. In this study, we examined sex differences in viral loads, SARS-CoV-2-specific antibody titers, plasma cytokines, as well as blood cell phenotyping in COVID-19 patients. By focusing our analysis on patients with moderate disease who had not received immunomodulatory medications, our results revealed that male patients had higher plasma levels of innate immune cytokines such as IL-8 and IL-18 along with more robust induction of non-classical monocytes. In contrast, female patients mounted significantly more robust T cell activation than male patients during SARS-CoV-2 infection, which was sustained in old age. Importantly, we found that a poor T cell response negatively correlated with patients’ age and was associated with worse disease outcome in male patients, but not in female patients. Conversely, higher innate immune cytokines in female patients associated with worse disease progression, but not in male patients. These findings reveal a possible explanation underlying observed sex biases in COVID-19, and provide an important basis for the development of a sex-based approach to the treatment and care of men and women with COVID-19.


https://www.inverse.com/mind-body/why-do-more...newsletter
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Health Net Invests $3 Million in Stockton Housing

Updated Category News Views 145

Putting a Roof Over Stockton's Head The talk of the town in Stockton is Health Net stepping up with a $3 million investment. This isn't just dropping loose change in a jar; it's about tackling a mammoth issue—making affordable housing more than just a pipe dream for 75 families. Community-driven, they say. What a cozy way to paint a picture of bridging that brutal gap...

Continue Reading
Partner Joins Yardi ICN, Boosting Data Quality for Clients

Updated Category News Views 91

Strategic Alliances in Real Estate Data When Partner Engineering and Science, Inc. says they're hooking up with the Yardi Independent Consultant Network (ICN), that's not just some boardroom handshake. It's a play that could shake up data services in the real estate game. Look, there's plenty of chatter about digitizing property management, but without killer data, those...

Continue Reading
Dyania, NVIDIA Team Up: AI Transforming Patient Care

Updated Category News Views 61

Revving up efficiency in healthcare usually sounds like pie-in-the-sky talk, but every now and again, an innovation comes along that really stirs the pot. Enter Dyania Health's Synapsis AI, a clinical reasoning AI, teaming with NVIDIA's robust computing infrastructure. They're setting out to make sense of massive amounts of patient data, securely tucked behind a...

Continue Reading
D-Wave's 9.5% Drop: Fraud Lawsuit Raises Investor Ire

Updated Category News Views 101

Shockwaves from D-Wave's Earnings Call August wasn't exactly a banner month for D-Wave Quantum, Inc. as their stock went down like a lead balloon following a lackluster earnings report. If you've ever had any skin in the game, you'd know a 9.5% drop isn't just peanuts—it's the equivalent of watching your prized racehorse stumble at the first hurdle. The financials spoke...

Continue Reading
Euroandinos Paita Closes Consent for 2037 Notes

Updated Category News Views 70

Port Strategy and Financial Implications Terminales Portuarios Euroandinos Paita S.A., nestled in the Peruvian transport sector, has been tight-rope walking through its debt landscape. Announcing a successful consent solicitation on November 13, 2026, they've taken a significant step towards reconfiguring their long-term financing game. This puppet show of paperwork...

Continue Reading
PenFed Fuels Aggie Spirit with Blackout Game Activation

Updated Category News Views 156

A Different Kind of Game Day Experience Ah, there's nothing quite like the vibrancy of a Texas A&M game day, especially when it's a blackout event. On November 14, fans aren't just getting the good old college football thrills; they're diving headfirst into an extravaganza, courtesy of PenFed Credit Union. You might know them as the go-to credit union for military folks,...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 46

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Fly-E Faces Revenue Drop Amid Retail Restructuring

Updated Category News Views 215

Downturn Despite Strategic Restructuring Today, we're diving into Fly-E Group, Inc. (NASDAQ:FLYE) and the latest shakeup in their financials—spoiler alert, it's riding a downward slope. Quarter two of fiscal 2027 didn't exactly shine a light on profitability. Net revenues slid, dropping to $2.6 million this quarter, down from $3.9 million the previous year. Tack that up...

Continue Reading
LA Fitness ELEVATE Opens at RITHM: A New Era Dawns

Updated Category News Views 66

Elevating Fitness at RITHM: A New Era Has Begun RD Management just dropped a new ace in Tampa Bay’s hand—LA Fitness ELEVATE at the RITHM at Uptown. They lit up the scene with this 30,000-square-foot beast of a gym, and I’ll tell you, it’s not your standard run-of-the-mill joint. When you toss twelve-and-a-half million bucks into a pot, you're aiming to lure folks...

Continue Reading
FiEE Rockets to Profitability with 382% Revenue Surge

Updated Category News Views 170

Big Moves in the Tech Jungle: FiEE's Comeback Let's chew the fat on FiEE, Inc., a company that's left its hardware-heavy past in the dust and grabbed the bull by the horns with fresh, AI-driven brand tech solutions. We're talking a whopping 382.1% revenue increase. Now, that's not chump change. From barely scraping $2 million last year to raking in $9.6 million just for...

Continue Reading

Top 5 Most Recently Viewed Articles

Cresilon Expands Reach with New VETIGEL Deal for Veterinarians

Updated Category News Views 267

Cresilon Partners with McCarthy Vet to Distribute VETIGEL Cresilon Inc., an innovative biotechnology firm known for its advanced hemostatic products, has announced a transformative agreement with McCarthy Vet. This collaboration marks a significant step forward as it allows for the distribution of VETIGEL, a groundbreaking hemostatic gel, directly to veterinary surgeons....

Continue Reading
Absci's Upcoming Financial Report and Business Highlights

Updated Category News Views 192

Absci Corporation's Upcoming Financial Reports Absci Corporation (Nasdaq: ABSI), recognized as a pioneer in data-driven generative AI for drug discovery, is gearing up to release important business updates along with financial results for the first quarter of 2025. This report is scheduled to be unveiled subsequent to market close. Key Highlights of the Upcoming Report...

Continue Reading
Upcoming Q2 2025 Results Announcement by Borregaard ASA

Updated Category News Views 186

Borregaard ASA's Second Quarter Results Announcement Borregaard ASA, a renowned name in biochemistry, is set to present its Q2 2025 results. This event will take place on Wednesday, coinciding with July 16, 2025, at 07:00 CEST. As anticipated, a comprehensive stock exchange announcement will follow shortly thereafter. What to Expect from the Presentation The presentation...

Continue Reading
JP Conte's Lupine Crest Pours $14M into Orizon Again

Updated Category News Views 29

JP Conte's Bet on Brazilian Waste-to-Energy Giant Here's the scoop, folks. Lupine Crest Capital, helmed by none other than JP Conte, just doubled down on their investment in Brazil. This isn't some negligible penny-ante increase, but a hefty infusion of R$70 million—think roughly $14 million in USD—into Orizon Valorização de Resíduos S.A., the notable...

Continue Reading
Hedge Funds Shift Strategies Amid Volatile U.S. Equity Markets

Updated Category News Views 121

Hedge funds adjusted their playbooks back then in 2023, net selling equities amid a flurry of options expiry and index rebalancing. The desks were abuzz as they noted slight selling pressure from these funds, yet after the dust settled on that chaotic week, buying picked up noticeably—especially Thursday when it seemed traders found some footing again. Macro Products...

Continue Reading